ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

Figure 1

ADAMTSL4 was enriched in GBM (WHO grade IV). (a) ADAMTSL4 was significantly higher expressed in GBM (WHO grade IV) to normal brain tissue and analyzed by GEPIA website (T: GBM WHO grade IV tumor; N: normal brain tissue). (b, c) ADAMTSL4 expression is significantly upregulated along with the WHO grade in the CGGA database (b) and TCGA dataset (c). 109 WHO grade II, 72 WHO grade III, and 144 WHO grade IV patients in the CGGA database and 223 WHO grade II, 245 WHO grade III, and 168 WHO grade IV patients in the TCGA database. and indicate and , respectively.

(a)

(b)

(c)